Suppression of ARID1A associated with decreased CD8 T cells improves cell survival of ovarian clear cell carcinoma.

Jung, Un Suk; Min, Kyueng Whan; Kim, Dong Hoon; Kwon, Mi Jung; Park, HoHyun; Jang, Hyung Seok

Jung, Un Suk; Min, Kyueng Whan; Kim, Dong Hoon; Kwon, Mi Jung; Park, HoHyun; Jang, Hyung Seok.

Afiliación

Jung US; Department of Obstetrics and Gynecology, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.
Min KW; Department of Pathology, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea. kyueng@gmail.com.
Kim DH; Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Kwon MJ; Department of Pathology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea.
Park H; Department of Biomedical Laboratory Science, Mokpo Science University, Mokpo, Korea.
Jang HS; Department of Clinical Laboratory Science, Ansan University, Ansan, Korea.

J Gynecol Oncol ; 32(1): e3, 2021 Jan.

Article en En | MEDLINE | ID: mdl-33185044

Asunto(s)

Adenocarcinoma de Células Claras; Neoplasias Ováricas; Adenocarcinoma de Células Claras/tratamiento farmacológico; Adenocarcinoma de Células Claras/genética; Linfocitos T CD8-positivos; Supervivencia Celular; Proteínas de Unión al ADN; Femenino; Humanos; Proteínas Nucleares/genética; Neoplasias Ováricas/tratamiento farmacológico; Neoplasias Ováricas/genética; Factores de Transcripción/genética; Factor A de Crecimiento Endotelial Vascular

Palabras clave

ARID1A Protein; Adenocarcinoma; Clear Cell; Human; Ovary

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Adenocarcinoma de Células Claras Tipo de estudio: Risk_factors_studies / Systematic_reviews Límite: Female / Humans Idioma: En Revista: J Gynecol Oncol Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google